Finally, using a mouse model of diabetes and human keratinocyte cell lines, Hu et al. (2024) observed that miR-221-3p directly targets DYRK1A and blocks glucose-induced DYRK1A-mediated STAT3 signaling and skin inflammation. This evidence concerns the gene DYRK1A and diabetes mellitus.